| Literature DB >> 35756497 |
Abstract
Objective: To evaluate the effect of standardized nutritional intervention in patients with nasopharyngeal carcinoma receiving radiotherapy complicated with diabetes mellitus and the impact on quality of life.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35756497 PMCID: PMC9217529 DOI: 10.1155/2022/6704347
Source DB: PubMed Journal: Dis Markers ISSN: 0278-0240 Impact factor: 3.464
Comparison of baseline data ().
| Groups |
| Male | Female | Age | Mean age | Course of disease | Mean course of disease |
|---|---|---|---|---|---|---|---|
| Observation group | 50 | 31 | 19 | 35-71 | 45.02 ± 3.68 | 3-11 | 7.02 ± 3.64 |
| Control group | 50 | 35 | 15 | 36-70 | 45.45 ± 3.34 | 3-11 | 7.56 ± 3.17 |
|
| — | — | — | — | 0.612 | — | 0.791 |
|
| — | — | — | — | 0.542 | — | 0.431 |
Comparison of blood glucose levels after intervention ().
|
|
| FBG (mmol/L) | 2Hpbg (mmol/L) | HbA1c (%) |
|---|---|---|---|---|
| Observation group | 50 | 6.58 ± 0.64 | 8.95 ± 0.35 | 8.06 ± 2.35 |
| Control group | 50 | 7.01 ± 0.62 | 9.86 ± 0.65 | 11.98 ± 2.36 |
|
| — | 3.412 | 8.716 | 8.323 |
|
| — | 0.001 | <0.001 | <0.001 |
Note: FBG: fasting blood glucose; 2hPBG: two-hour postprandial blood glucose; HbA1c: glycated hemoglobin.
Comparison of nutritional status related blood indices ().
| Groups |
| Timepoint | Hb (g/L) | PA (mg/L) | ALB (g/L) |
|---|---|---|---|---|---|
| Observation group | 50 | Before intervention | 132.65 ± 11.16 | 271.17 ± 23.43 | 44.02 ± 3.98 |
| At 4 weeks of intervention | 131.17 ± 10.77 | 268.07 ± 22.32 | 42.78 ± 4.12 | ||
| At the end of intervention | 130.55 ± 10.86 | 267.25 ± 19.78 | 41.17 ± 3.76 | ||
| Control group | 50 | Before intervention | 131.84 ± 12.04 | 270.61 ± 21.19 | 43.75 ± 4.23 |
| At 4 weeks of intervention | 123.76 ± 11.25 | 234.95 ± 16.44 | 37.83 ± 4.33 | ||
| At the end of intervention | 106.73 ± 9.88 | 210.07 ± 14.56 | 34.82 ± 1.77 | ||
|
| — | Before intervention | 0.349 | 0.125 | 0.329 |
| At 4 weeks of intervention | 3.364 | 8.448 | 5.856 | ||
| At the end of intervention | 11.472 | 16.462 | 10.805 | ||
|
| — | Before intervention | 0.728 | 0.901 | 0.743 |
| At 4 weeks of intervention | 0.001 | <0.001 | <0.001 | ||
| At the end of intervention | <0.001 | <0.001 | <0.001 |
Note: t-values and P values are for the same period comparison between the two groups. Hb: hemoglobin; PA: prealbumin; ALB: albumin.
Figure 1Comparison of Morisky scores. Note: ∗ indicates the differences between the two groups were statistically significant; (a) is the comparison of control body mass; (b) is the comparison of medication compliance; (c) is the comparison of appropriate exercise; (d) is the comparison of control diet.
Comparison of FACT-H&N scores ().
| Groups |
| Before intervention | After intervention |
|---|---|---|---|
| Observation group | 50 | 105.87 ± 5.65 | 91.27 ± 7.68∗ |
| Control group | 50 | 106.09 ± 5.73 | 79.88 ± 5.37∗ |
|
| — | 0.193 | 8.594 |
|
| — | 0.847 | <0.001 |
Note: ∗ is a statistically significant difference between pre- and postintervention in the same group, P < 0.05.
Comparison of incidence of adverse events (%).
| Groups |
| Radioactive skin injury | Radioactive mucositis | Oral ulcers | Difficulty in opening mouth | Otitis media | Dry mouth |
|---|---|---|---|---|---|---|---|
| Observation group | 50 | 2 (4.00) | 2 (4.00) | 3 (6.00) | 1(2.00) | 0 (0.00) | 2 (4.00) |
| Control group | 50 | 8 (16.00) | 9 (18.00) | 12 (24.00) | 7 (14.00) | 4 (8.00) | 9 (18.00) |
|
| — | 4.000 | 5.005 | 6.353 | 4.891 | 4.167 | 5.005 |
|
| — | 0.046 | 0.025 | 0.012 | 0.027 | 0.041 | 0.025 |
Figure 2Comparison of SF-36 scores. Note: ∗ indicates the differences between the two groups were statistically significant.